SAT0290 Canadian adalimumab post-marketing observational epidemiological study assessing the effectiveness of adalimumab vs. non-biologic dmards in ankylosing spondylitis (COMPLETE-AS): 12-month effectiveness data

Background COMPLETE-AS is an ongoing Canadian observational study of anti-TNFα naïve adults with active AS per the judgment of the treating physician, who require change in current AS treatment to either1 a subsequent NSAID or non-biologic disease modifying antirheumatic drug (nbDMARD group), or2 to adalimumab (ADA group). Objectives The aim of this analysis was to describe and compare the baseline demographic and disease parameters of patients …